Motexafin gadolinium
Motexafin gadolinium (proposed tradename Xcytrin) is an inhibitor of thioredoxin reductase and ribonucleotide reductase. It has been proposed as a possible chemotherapeutic agent in the treatment of brain metastases.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Motexafin gadolinium
Motexafin gadolinium (proposed tradename Xcytrin) is an inhibitor of thioredoxin reductase and ribonucleotide reductase. It has been proposed as a possible chemotherapeutic agent in the treatment of brain metastases.
has abstract
Motexafin gadolinium (proposed ...... treatment of brain metastases.
@en
CAS number
156436-89-4
ChEBI
FDA UNII code
6433A42F4F
KEGG
PubChem
Wikipage page ID
10,942,957
page length (characters) of wiki page
Wikipage revision ID
992,831,096
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChEBI
ChemSpiderID
image
@en
KEGG
D05080
@en
PubChem
SMILES
CCC1=CCC.CC[O-].CC[O-].[Gd+3]
@en
StdInChIKey
VAZLWPAHMORDGR-WRIGXHCHSA-L
@en
verifiedrevid
447,766,566
wikiPageUsesTemplate
subject
hypernym
comment
Motexafin gadolinium (proposed ...... treatment of brain metastases.
@en
label
Motexafin gadolinium
@en